Get the Stockscreener App
24.61
1.41%
-0.19
Orthopediatrics Corp stock is traded at $24.61, with a volume of 130.91K.
It is down -1.41% in the last 24 hours and up +27.24% over the past month.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.
See More
Previous Close:
$24.80
Open:
$24.75
24h Volume:
130.91K
Relative Volume:
0.79
Market Cap:
$642.56M
Revenue:
$243.30M
Net Income/Loss:
$-39.68M
P/E Ratio:
-14.63
EPS:
-1.6825
Net Cash Flow:
$-14.64M
1W Performance:
+5.03%
1M Performance:
+27.24%
6M Performance:
+43.40%
1Y Performance:
+27.41%
1-Day Range:
$24.37
$25.16
1-Week Range:
$23.07
$25.35
52-Week Range:
$14.42
$25.35
Orthopediatrics Corp Stock (KIDS) Company Profile
Name
Orthopediatrics Corp
Sector
Industry
Phone
574-268-6379
Address
2850 FRONTIER DRIVE, WARSAW, IN
Compare KIDS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KIDS
Orthopediatrics Corp
|
24.61 | 647.52M | 243.30M | -39.68M | -14.64M | -1.6825 |
ABT
Abbott Laboratories
|
110.06 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
332.34 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.64 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.56 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.78 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Orthopediatrics Corp Stock (KIDS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | TD Cowen | Buy |
| Dec-10-25 | Initiated | Canaccord Genuity | Buy |
| Apr-07-25 | Initiated | Lake Street | Buy |
| Jan-25-24 | Downgrade | Truist | Buy → Hold |
| Jun-14-21 | Reiterated | Needham | Buy |
| Apr-02-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jun-19-19 | Initiated | Needham | Buy |
| Feb-20-19 | Initiated | JMP Securities | Mkt Outperform |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
View All
Orthopediatrics Corp Stock (KIDS) Latest News
OrthoPediatrics Lifts 2026 Outlook on Record Q2 - TipRanks
OrthoPediatrics Sees ‘Inflection Point’ as New Products Fuel Record Quarter - MarketBeat
OrthoPediatrics Corp. Hits New 52-Week High at $25.13 - MarketsMojo
Wasatch Advisors LP Buys 186,357 Shares of OrthoPediatrics Corp. $KIDS - marketbeat.com
OrthoPediatrics at canaccord growth conference: growth engine broadens - Investing.com
OrthoPediatrics (NASDAQ:KIDS) Sets New 1-Year HighHere's Why - marketbeat.com
OrthoPediatrics (KIDS) Q2 2026 Earnings Call Transcript - aol.com
Understanding the Setup: (KIDS) and Scalable Risk - Stock Traders Daily
Dimensional Fund Advisors LP Has $8.67 Million Stake in OrthoPediatrics Corp. $KIDS - marketbeat.com
OrthoPediatrics Corp. (KIDS) Investor Outlook: A 10.97% Potential Upside with Solid Buy Ratings - DirectorsTalk Interviews
OrthoPediatrics (NASDAQ:KIDS) Sets New 12-Month High on Analyst Upgrade - MarketBeat
OrthoPediatrics Announces Q2 2026 Financial Results with Revenue Growth and Reduced Operating Loss - Kalkine Media
Orthopediatrics Corp Q2 2026: Revenue $70.5M, EPS $(0.30) — 10-Q Summary - TradingView
OrthoPediatrics Corp. Q2 2026 Earnings Call Summary - Yahoo Finance
OrthoPediatrics (NASDAQ:KIDS) Given New $35.00 Price Target at Needham & Company LLC - marketbeat.com
Truist Adjusts Price Target on OrthoPediatrics to $22 From $20, Maintains Hold Rating - Yahoo Finance
OrthoPediatrics Corp. Stock 12‑Month Price Target Raised to $26.67, Implies 28% Upside - TradingView
OrthoPediatrics Corp (KIDS) (Q2 2026) Earnings Call Highlights: Record Revenue and EBITDA ... By GuruFocus - Investing.com Canada
OrthoPediatrics Corp (KIDS) (Q2 2026) Earnings Call Highlights: Record Revenue and EBITDA ... - Yahoo Finance
ORTHOPEDIATRICS CORP : NEEDHAM RAISES TARGET PRICE TO $35 FROM $30 - Bitget
OrthoPediatrics Q2 Earnings Call Highlights - MarketBeat
OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: OrthoPediatrics raises 2026 revenue outlook on strong Q2 - Investing.com Nigeria
Orthopediatrics earnings matched, revenue topped estimates - Investing.com
OrthoPediatrics Highlights Growth in 2026 Investor Presentations - TipRanks
OrthoPediatrics Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Transcript : OrthoPediatrics Corp., Q2 2026 Earnings Call, Aug 04, 2026 - marketscreener.com
OrthoPediatrics: Q2 Earnings Snapshot - Barchart.com
OrthoPediatrics (NASDAQ: KIDS) eyes $265M–$269M 2026 revenue, cash breakeven - stocktitan.net
Orthopediatrics reports Q2 revenue $70.5M, adjusted EBITDA $6.8M; raises 2026 revenue guidance - TradingView
OrthoPediatrics (Nasdaq: KIDS) lifts 2026 guidance after strong Q2 growth - Stock Titan
OrthoPediatrics Corp. Increases Earnings Guidance for the Full Year 2026 - marketscreener.com
OrthoPediatrics Corp. (NASDAQ:KIDS) Given Consensus Rating of "Moderate Buy" by Analysts - marketbeat.com
OrthoPediatrics Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com
OrthoPediatrics Corp. (KIDS) Stock Analysis: 24% Potential Upside Amid Strong Buy Ratings - DirectorsTalk Interviews
The Technical Signals Behind (KIDS) That Institutions Follow - Stock Traders Daily
OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings: Narrowing Loss Beats Estimates, Stock Edges Higher - dars.gov.et
OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings: Narrower Loss Beats Estimates, Shares Edge HigherEarnings Risk Report - dars.gov.et
OrthoPediatrics to Participate in the Canaccord Genuity 46th Annual Growth Conference - The Manila Times
OrthoPediatrics execs to speak at Canaccord Gen... - Pluang
OrthoPediatrics (KIDS) Projected to Post Quarterly Earnings on Tuesday - marketbeat.com
Medical device manufacturer gets a new backbone after global takeover - TheBusinessDesk.com
OrthoPediatrics Corp. Revenue Breakdown – SWB:2X7 - TradingView
KIDS|OrthoPediatrics Corp|Price:18.840|Chg%:+0.120 - TradingKey
OrthoPediatrics Corp. (KIDS) Stock Analysis: Exploring a Potential 33.55% Upside in the Pediatric Orthopedic Market - DirectorsTalk Interviews
OrthoPediatrics Corp (KIDS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings: Narrower-Than-Expected Loss Supports SentimentRevenue Guidance Update - dars.gov.et
OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings: Narrowed Loss Beats Estimates Amid Operational Discipline - dars.gov.et
OrthoPediatrics to report Q2 2026 financial results on August 4 - scanx.trade
OrthoPediatrics Corp. (KIDS) Holds Steady Near Support Amid Low VolatilityPost-Earnings Moves - po-news-eg.net
OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 4, 2026 - GlobeNewswire
Orthopediatrics Corp Stock (KIDS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Orthopediatrics Corp Stock (KIDS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hite Fred | COO and CFO |
Mar 16 '26 |
Sale |
17.25 |
12,993 |
224,129 |
277,477 |
| Bailey David R | President and CEO |
Mar 16 '26 |
Sale |
17.25 |
19,535 |
336,979 |
298,020 |
| Odle Gregory A | President of Scoliosis |
Mar 16 '26 |
Sale |
17.25 |
8,433 |
145,469 |
187,735 |
| Gerritzen Daniel J | General Counsel and Secretary |
Mar 16 '26 |
Sale |
17.25 |
8,614 |
148,592 |
149,533 |
2.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):